| Primary |
| Product Used For Unknown Indication |
61.9% |
| Epididymitis |
19.0% |
| Orchitis |
19.0% |
|
| Rash Morbilliform |
50.0% |
| Multiple Drug Overdose |
25.0% |
| Respiratory Depression |
25.0% |
|
| Secondary |
| Product Used For Unknown Indication |
19.9% |
| Depression |
12.5% |
| Pain |
12.1% |
| Headache |
8.8% |
| Neck Pain |
6.5% |
| Anxiety |
5.8% |
| Psychotic Disorder |
5.4% |
| Insomnia |
4.2% |
| Migraine |
4.2% |
| Back Pain |
3.2% |
| Influenza |
2.5% |
| Prophylaxis |
2.5% |
| Pain In Extremity |
1.8% |
| Psoriatic Arthropathy |
1.8% |
| Cough |
1.6% |
| Acute Tonsillitis |
1.4% |
| Ill-defined Disorder |
1.4% |
| Multiple Drug Overdose Intentional |
1.4% |
| Pyrexia |
1.4% |
| Suicide Attempt |
1.4% |
|
| Angioedema |
10.7% |
| Faeces Hard |
10.7% |
| International Normalised Ratio Increased |
8.9% |
| Swelling Face |
7.1% |
| Henoch-schonlein Purpura |
5.4% |
| Liver Disorder |
5.4% |
| Liver Function Test Abnormal |
5.4% |
| Abdominal Distension |
3.6% |
| Anaemia |
3.6% |
| Autoimmune Hepatitis |
3.6% |
| Bladder Neoplasm |
3.6% |
| Gastrointestinal Haemorrhage |
3.6% |
| Gastrooesophageal Reflux Disease |
3.6% |
| Jaundice |
3.6% |
| Mucous Membrane Disorder |
3.6% |
| Multiple Drug Overdose |
3.6% |
| Nausea |
3.6% |
| Pelvic Pain |
3.6% |
| Polyp |
3.6% |
| Rash Morbilliform |
3.6% |
|
| Concomitant |
| Juvenile Arthritis |
21.7% |
| Prophylaxis |
8.9% |
| Product Used For Unknown Indication |
8.6% |
| Rheumatoid Arthritis |
7.8% |
| Pain |
7.4% |
| Hypertension |
7.3% |
| Drug Use For Unknown Indication |
5.3% |
| Deafness |
3.9% |
| Tonsillitis |
3.9% |
| Pharyngitis |
3.6% |
| Sjogren's Syndrome |
2.7% |
| Postoperative Care |
2.5% |
| Bronchitis |
2.4% |
| Nausea |
2.4% |
| Relapsing-remitting Multiple Sclerosis |
2.1% |
| Adverse Drug Reaction |
2.0% |
| Hiv Infection |
2.0% |
| Vitamin Supplementation |
2.0% |
| Oral Herpes |
1.9% |
| Abdominal Pain Upper |
1.7% |
|
| Hepatitis B |
13.5% |
| Pyrexia |
9.5% |
| Liver Disorder |
7.4% |
| Cerebral Infarction |
6.8% |
| Squamous Cell Carcinoma |
6.8% |
| White Blood Cell Count Decreased |
6.8% |
| Melaena |
5.4% |
| Arthritis |
4.7% |
| Diarrhoea |
4.1% |
| Interstitial Lung Disease |
4.1% |
| Malaise |
4.1% |
| Pneumonia |
4.1% |
| Prostate Cancer |
3.4% |
| Renal Impairment |
3.4% |
| Erythema |
2.7% |
| Erythema Nodosum |
2.7% |
| Febrile Neutropenia |
2.7% |
| Lung Neoplasm Malignant |
2.7% |
| Neurogenic Bladder |
2.7% |
| Skin Ulcer |
2.7% |
|
| Interacting |
| Product Used For Unknown Indication |
37.7% |
| Pneumonia Bacterial |
16.4% |
| Psoriatic Arthropathy |
16.4% |
| Back Disorder |
8.2% |
| Prophylaxis |
8.2% |
| Drug Use For Unknown Indication |
3.3% |
| Chronic Obstructive Pulmonary Disease |
1.6% |
| Cranial Nerve Disorder |
1.6% |
| Diabetes Mellitus |
1.6% |
| Herpes Zoster |
1.6% |
| Hypertension |
1.6% |
| Personality Change Due To A General Medical Condition |
1.6% |
|
| Gastrointestinal Inflammation |
28.6% |
| Cytomegalovirus Test Positive |
14.3% |
| Enterocolitis Haemorrhagic |
14.3% |
| Haemorrhoids |
14.3% |
| Loss Of Consciousness |
14.3% |
| Shock |
14.3% |
|
